Sep 2026· Journal of Genetic Counseling· Vol 35 5, pp.
e70267
· 0 citations· 16 references
Medicine
TL;DR
The findings highlight barriers to SOC genetic evaluation and underscore the need to strengthen institutional protocols, enhance provider education, and develop stillbirth-specific genetic counseling guidelines.
Abstract
Stillbirth affects approximately 1 in 175 pregnancies annually in the United States. Although the American College of Obstetricians and Gynecologists recommends genetic testing as part of the stillbirth evaluation, families often face barriers to obtaining a complete evaluation. Expansion of the diagnostic evaluation of stillbirth is expected to include exome/genome sequencing, with preliminary studies demonstrating its diagnostic utility. Consequently, genetic counselors (GCs) are expected to play an expanding role in post-stillbirth care. This study explored current genetic counseling practices for stillbirth and GCs' preparedness to support patients in this setting. A cross-sectional survey was distributed across four channels. Eligible participants included GCs in the United States and Canada with at least 1 year of prenatal experience. The survey assessed GC frequency and timing in stillbirth counseling, genetic testing practices, comfort addressing psychosocial needs, and perceived barriers to care. Responses were analyzed using descriptive statistics. Group comparisons were performed using Chi-square and Fisher's exact tests. Open-ended responses were coded for themes. Seventy-one responses were analyzed. Approximately half of respondents (49.3%, n = 36) reported "never/very rarely/rarely" counseling patients postpartum, despite this being the optimal time to offer genetic testing. Delivering providers (46.5%, n = 33) were often responsible for informing patients about testing and obtaining consent, compared to GCs (11.3%, n = 8). Although chromosomal microarray (CMA) is recommended as the standard of care (SOC), 12.7% (n = 9) of GCs reported not offering CMA for anomalous and non-anomalous stillbirths. Perceived barriers to SOC testing included reported lack of obstetrician awareness (91.5%, n = 65) and challenges coordinating specimen collection (90.1%, n = 64). These findings highlight barriers to SOC genetic evaluation and underscore the need to strengthen institutional protocols, enhance provider education, and develop stillbirth-specific genetic counseling guidelines. GC involvement in these efforts will be essential to promoting equitable access to comprehensive post-stillbirth care as sequencing becomes integrated into practice.
Therapeutic advances and the rapid, cost-effective development of next-generation sequencing (NGS) have increased interest in expanding newborn screening (NBS) through genomics. The SeDeN-p2 study assessed the acceptability among healthcare professionals in France, of expanding NBS, particularly with genetics as a firs...
Camille Level, Frédéric Huet, Dominique Salvi et al.· European Journal of Human Ge...· 0 citations
In this review, we describe current genetic testing modalities available for pediatricians, provide guidance on test selection and result interpretation, and inform providers on proper genetic testing consent practices. For each type of genetic test, details regarding types of mutations detected, limitations, and commo...
Jonathan B. Trapani, John A. Phillips, Scott K. Ward· Current Pediatrics Reports· 0 citations
Genetic counseling and germline genetic testing are essential components of ovarian cancer care; however, their implementation in routine clinical practice remains inconsistent. This study aimed to evaluate the utilization of genetic counseling and testing among patients with ovarian cancer and identify barriers to imp...
W. Shaalan, N. Dikow, F. Kommoss et al.· BMC Women's Health· 0 citations
This review aims to provide a brief historical overview of genetic counseling and its evolution, addressing the qualified professionals and clinical requirements necessary to obtain a diagnosis and post-test guidance across different stages of patients' lives. Recent advances in the understanding of genetic diseases an...
A. Perez, M. Cernach, M. Migliavacca· Current Pediatrics Reports· 0 citations
INTRODUCTION
Prenatal genetic screening and diagnostic tests (PS&D) are a core component of the delivery of high-quality, evidence-based prenatal care. There is a paucity of evidence on how to structure decision-making processes that are responsive to rapid advances in prenatal genetics, perinatology, and neonatology,...
Miller S. Finkelstein, John F. P. Bridges, Norah L. Crossnohere et al.· Medical decision making· 0 citations
Prenatal genetic tests are routinely offered to patients within Switzerland. As these technologies are continuing to advance, it is important to understand the ethical and societal values that shape their implementation.
We conducted an integrative literature review, examining the medical and ethics litera...
Kirsten A. Riggan, Eirini Petrou, Yi Han et al.· Archives of Gynecology and O...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.